More Potent Than CBD, Naturally: CTFO Reveals Discovery of Stabilized Cannabinoid Acid Molecules
Ryan Allway
May 12th, 2021
News
RENO, Nev., May 12, 2021 /PRNewswire/ — CTFO, Inc. (CTFO) set out to prove that its proprietary delivery oil 10xPURE™ could deliver bioavailable oily cannabinoids through your normally 60% aqueous body. CTFO announces a surprising and unexpected discovery: the ability to stabilize cannabinoid acid molecules such as CBDa, making the seemingly impossible, possible. This cannabinoid-acid stability milestone is supported by documented lab results with no meaningful potency degradation of the acids.
General Sequence of Events:
– In January 2019 CTFO commissioned an Exploratory Scientific Endeavor using CTFO 10xPURE™ delivery technology to demonstrate increased absorption and bioavailability of oily cannabinoids. CTFO unexpectedly discovered that this proprietary technology also stabilized the cannabinoid acids such as CBDa.
– In April 2019 CTFO published the Exploratory Scientific Endeavor on their website with data showing increased absorption, bioavailability and protection of the cannabinoid acid molecules.
– In July 2019 CTFO launched the first of its kind product to the public, 10xPURE™ SUPER 1000 containing 300 mgs of CBDa and 700 mgs of cannabinoids.
– In Jan. 2021 CTFO launched another industry first, BLISS – extra-strength happy containing 200mgs of CBGa.
– In May, 2021 CTFO is committed to enhance our 10xPURE™ cannabinoid acid stabilization and a new-era of product development with our partners based on over 18 months of promising personal anecdotes. FortuneBusinessinsights.com, a research company, reports global CBD market size projected at $39.99 billion by 2027, a 46.4% compound annual growth rate. CTFO believes a large percentage of that business could theoretically be cannabinoid acids formulated individually, together or in combination with CBD.
“The launch of CTFO’s original 10xPURE™ Super 1000 brand, enriched with 300mgs CBDa, in July 2019 marked the beginning of a new era in harnessing the natural cannabinoid acid molecules for potential therapeutic benefit,” said Stuart Finger, Chief Executive Officer, CTFO.
Under the guidance of David D’Arcangelo, Global Marketing Director, CTFO has focused on cannabinoid acid molecules that have long been theorized to be significantly more potent than CBD for specific therapeutic benefit. “The addition of new President Kevin Fournier last week supports CTFO’s goal of expanding global network sales & marketing distribution supported by fair pricing and equal access for all,” said David D’Arcangelo.
About CTFO
CTFO, founded in 2015, is a US-based health & wellness company doing business in the U.S.A., Canada and fifteen other European countries. CTFO acquires, discovers, formulates and distributes product solutions direct to consumers through its independent associates network sales & marketing teams. CTFO’s vision –provide tools to empower people in business, health and serving others; demonstrating the good news with quality, integrity and generosity. For more information, visit www.myctfo.com.
Contact: David D’Arcangelo,
Global Marketing Director
david@ctfoteam.com
619-921-6560
Corporate News:
To be notified of CTFO corporate announcements just click corporate news.
SOURCE CTFO, Inc.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Ryan Allway
Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Tom Zuber is Zuber Lawler & Del Duca’s Managing Partner. He has a degree with highest honors in biomedical engineering and has advised some of the most iconic companies in the world on their patent and trademark portfolios. He is at the cutting edge of cannabis patent and trademark law. He holds degrees from Harvard University and Columbia Law […]
Matt Hawkins is the founder and managing principal of Cresco Capital Partners, LLC (“Cresco”), a private equity firm focused specifically on investing in the legalized cannabis industry. Since its inception in the summer of 2015, Cresco has made 14 investments out of its first fund and is currently raising this fund, Fund II. Prior to the […]
Helix TCS, Inc. (OTCQB: HLIX) provides software and technology platforms for the cannabis industry.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
